Announced selection of IL15-superagonist as first payload to be delivered into tumors with Calidi’s first lead candidate using its systemic antitumor virotherapy platform, Redtail; IND filing expected ...

In April 2025, the Company announced that the first patient had been dosed in Part 2a of the Phase 2 DENALI clinical trial ( NCT05128825) of azenosertib in patients with Cyclin E1+ platinum-resistant ...

Many investors have never heard of Eurofins Scientific, yet this French-based global leader in testing is woven into the ...

"We look forward to working with Veloxity Labs for GLP sample analysis in our current safety study of SPC-15,” said Eric ...

SINGAPORE, May 14, 2025 /PRNewswire/ -- Canaan Inc. (NASDAQ: CAN) (" Canaan " or the "Company"), an innovator in crypto mining, today released its unaudited bitcoin mining update for the month ending ...

Allseas Group SA affiliate facility of $25 million was terminated by mutual agreement in Q1 2025 as maturity was approaching and no amounts were outstanding, while the maturity of the $7.5 million ...